
==== Front
Radiol Med
Radiol Med
La Radiologia Medica
0033-8362
1826-6983
Springer Milan Milan

38918291
1831
10.1007/s11547-024-01831-w
Diagnostic Imaging in Oncology
What the urologist needs to know before radical prostatectomy: MRI effective support to pre-surgery planning
http://orcid.org/0000-0001-8375-0912
Laschena Ludovica 1
http://orcid.org/0000-0003-4395-2872
Messina Emanuele 1
http://orcid.org/0000-0002-3129-0544
Flammia Rocco Simone 23
http://orcid.org/0009-0003-3621-2056
Borrelli Antonella 1
http://orcid.org/0000-0003-2797-8925
Novelli Simone 45
http://orcid.org/0000-0003-3059-4439
Messineo Daniela 1
http://orcid.org/0000-0003-1407-0424
Leonardo Costantino 2
http://orcid.org/0000-0002-7899-8056
Sciarra Alessandro 6
http://orcid.org/0000-0001-8480-6236
Ciardi Antonio 1
http://orcid.org/0000-0003-4208-9691
Catalano Carlo 1
http://orcid.org/0000-0002-3091-8192
Panebianco Valeria valeria.panebianco@gmail.com

1
1 https://ror.org/02be6w209 grid.7841.a Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy
2 grid.417520.5 0000 0004 1760 5276 Department of Urology, IRCCS Regina Elena National Cancer Institute, Rome, Italy
3 https://ror.org/02be6w209 grid.7841.a Department of Surgery, Sapienza University of Rome, Rome, Italy
4 https://ror.org/02be6w209 grid.7841.a Department of Mechanical and Aerospace Engineering, Sapienza University of Rome, Rome, Italy
5 https://ror.org/01ge67z96 grid.426108.9 0000 0004 0417 012X Liver Failure Group, Institute for Liver and Digestive Health, UCL Medical School, Royal Free Hospital, London, UK
6 https://ror.org/02be6w209 grid.7841.a Department of Maternal-Infant and Urological Sciences, Sapienza University of Rome, Rome, Italy
25 6 2024
25 6 2024
2024
129 7 10481061
17 12 2023
23 5 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Background

Radical prostatectomy (RP) is recommended in case of localized or locally advanced prostate cancer (PCa), but it can lead to side effects, including urinary incontinence (UI) and erectile dysfunction (ED). Magnetic resonance imaging (MRI) is recommended for PCa diagnosis and staging, but it can also improve preoperative risk-stratification.

Purpose

This nonsystematic review aims to provide an overview on factors involved in RP side effects, highlighting anatomical and pathological aspects that could be included in a structured report.

Evidence synthesis

Considering UI evaluation, MR can investigate membranous urethra length (MUL), prostate volume, the urethral sphincter complex, and the presence of prostate median lobe. Longer MUL measurement based on MRI is linked to a higher likelihood of achieving continence restoration. For ED assessment, MRI and diffusion tensor imaging identify the neurovascular bundle and they can aid in surgery planning. Finally, MRI can precisely describe extra-prostatic extension, prostate apex characteristics and lymph-node involvement, providing valuable preoperative information for PCa treatment.

Conclusions

Anatomical principals structures involved in RP side effects can be assessed with MR. A standardized MR report detailing these structures could assist urologists in planning optimal and tailored surgical techniques, reducing complications, and improving patients’ care.

Keywords

Prostate cancer
Radical prostatectomy
Urinary incontinence
Erectile dysfunction
Magnetic resonance imaging
Risk-stratification
Università degli Studi di Roma La SapienzaOpen access funding provided by Università degli Studi di Roma La Sapienza within the CRUI-CARE Agreement.

issue-copyright-statement© Italian Society of Medical Radiology 2024
==== Body
pmcIntroduction

Prostate cancer (PCa) is a complex disease, mostly due to its multifactorial etiology, and therefore it should be promptly recognized at an early stage [1]. Indeed, when diagnosed at an advanced stage, PCa is often aggressive and it requires multimodal therapy [2]. Radical prostatectomy (RP) is recommended in case of localized or locally advanced disease, with or without extended lymph node dissection (eLND) [3]. RP procedures have progressed from perineal and retropubic open approaches to laparoscopic and robotic-assisted techniques [4].

RP-related risks are in the same associated to any other major surgery; nevertheless in some cases we can witness some side effects, more frequently urinary incontinence (UI) and erectile disfunction (ED) [5, 6]. UI etiology is multifactorial, but damages to anatomic support and pelvic innervation have been indicated as important causing factors [7]. Furthermore, despite the increasing spread of nerve-sparing approaches, the ED related to neuropraxia remains a relatively common consequence [7].

Considering the diagnostic PCa work-up, magnetic resonance imaging (MRI) is indicated by all the major international guidelines as a key tool for PCa detection and staging, being noninvasive and representing the base of prostate biopsy planning [8–11]. Prostate mpMRI should be acquired and reported using Prostate Imaging Reporting & Data System version 2.1 (PI-RADS v2.1) recommendations [12] according to the European Association of Urology (EAU) guidelines [5]. Other important advantages of performing MRI are that it can improve preoperative risk stratification and it can describe predisposing factors leading to RP side effects [13].

Therefore, the aim of this nonsystematic narrative review is to provide an overview of these factors, highlighting the anatomical and pathological aspects that should be included in a structured report. A precise and comprehensive report could significantly aid urologists on the pre-surgery planning, furnishing insightful data.

Evidence acquisition

This nonsystematic narrative review was performed using existing literature on RP techniques, principal side effects and MR potential role in pre-surgery planning.

Online databases (Medline, PubMed, and Web of Science) were searched for original articles, systematic review and meta-analysis, expert opinion papers and international guidelines.

Prostate anatomy

The prostate gland is a dense fibromuscular gland located in the pelvis directly below the bladder and surrounding the proximal urethra. The gland is enclosed by a fibrous capsule, with nerves and vascular bundle which is surrounded by a visceral layer of the pelvic fascia. It is composed by three anatomical zones presenting different histology: (1) the central zone constitutes the base of the gland enclosing the ejaculatory ducts; (2) the peripheral zone represents the largest zone and surrounds most of the central zone and partially the distal part of the prostatic urethra; it is the area most frequently involved by cancer; (3) the transition zone is a small glandular zone surrounding a portion of the urethra between the urinary bladder and the verumontanum. An additional anterior area can be described, and it is composed by fibromuscular stroma [14–17]. A key structure is represented by the neurovascular bundle (NVB), which is composed by vessels and neural fibers arising from the inferior hypogastric plexus (IHP) and the cavernous nerves (CN), which themselves arises from the lower portion of the IPH. The IHP, comprising fibers from both the sympathetic and parasympathetic systems, plays a crucial role in the processes of erection, ejaculation, and urinary continence; the CN are involved in the erectile function. The NVB also encompasses nerve fibers directed to structures such as the urethral sphincter. The NVB is predominantly located posterior and lateral to the prostate; only minimal nerve fibers are observed on the anterior surface of the bladder neck and the prostate. Caution is necessary during the dissection of the lateral prostatic pedicles at the prostatic base, as the NVB is closely located. There is a risk of injury to the NVB during the ligation and dissection of the pedicles or due to traction on the surrounding tissues [18, 19].

Prostate cancer local staging

For tumor staging, the Tumor, Node, Metastasis (TNM) system is universally applied, reflecting intrinsic characteristics of tumor aggressiveness, and considering a schematic representation of tumor extent and pathological tumor grade (Table 1) [20]. Another widely accepted classification system is the EAU risk grouping, which is essentially based on D’Amico’s classification system. It combines clinical information on tumor extent, PSA and pathology results [5, 21] (Table 2). EAU guidelines strongly recommend using the TNM classification for PCa staging and EAU risk group stratification for prognostic subgrouping of patients. Moreover, they still assess that clinical stage should be based on digital rectal examination (DRE) only and that additional staging data furnished by imaging should be reported separately [5].Table 1 Risk grouping of prostate cancer adapted from European Association of Urology [5]

Localized prostate cancer	
 Low-risk	PSA < 10 ng/mL and GS < 7 (ISUP grade I) and cT1-2a*	
 Intermediate-risk	PSA 10–20 ng/mL or GS 7 (ISUP grade 2/3) or cT2b*	
Locally advanced prostate cancer	
 High-risk	- PSA > 20 ng/mL or GS > 7 (ISUP grade 4/5) or cT2c*

- any PSA, any GS (any ISUP grade) and cT3-4* or cN + §

	
*Based on digital rectal examination

§Based on CT/bone scan

PSA, prostate specific antigen; GS, Gleeson Score; ISUP, International Society of Urological Pathology

Table 2 Prostate cancer Tumor, Node, Metastasis staging system

T-stage	
Tx

T0

	Primary tumor cannot be assessed

No evidence of primary tumor

	
T1

T1a

T1b

T1c

	Clinically inapparent tumor not palpable nor visible by imaging

Incidental tumor ≤ 5% of tissue

Incidental tumor > 5% of tissue

Tumor detected by needle biopsy

	
T2

T2a

T2b

T2c

	Organ confined and palpable tumor

One half of one lobe involved

More than half of one lobe (not both)

Both lobes

	
T3

T3a

T3b

	Palpable extension through prostate capsule

Extracapsular extension (uni- or bilateral)

Invasion of seminal vesicles

	
T4	Tumor invades external sphincter, rectum, levetor muscle, pelvic side wall	
N Stage	
Nx

N0

	Regional nodes cannot assessed

No regional lymph nodes (below level of bifurcation of common iliac arteries)

	
N1	Regional node metastases – including pelvic, hypogastric, obturator, iliac, sacral	
M stage	
M0	No distant metastasis	
M1

M1a

M1b

M1c

	Distant metastasis

Non regional lymph nodes

Bone

Other site(s)

	

Surgical treatment

Radical prostatectomy

Radical prostatectomy (RP) is recommended in case of localized or locally advanced disease, and it can be performed with open, laparoscopic, and robot-assisted approaches. The open RP can be performed via perineal or retropubic approaches, even if this technique is now obsolete. The robot-assisted technique introduced the combination of minimally invasive advantages of laparoscopic RP with improved surgeon ergonomics and greater technical ease of the reconstruction of the vesicourethral anastomosis [5].

Currently, the main surgical approach in use is the nerve-sparing technique, which can maintain the integrity of the NVB. This approach is envisioned considering the distance between the NVB and the foci of prostate cancer in the specimen evaluated during the procedure [22]. Indeed, to date there is no consensus on standardized clinical and radiological information that could set specific indications in this setting. Nerve sparing technique is crucial for postoperative side effects, but is correlated with an higher risk of positive surgical margins [23].

A novel robotic technique is represented by Retzius-Sparing Robot-Assisted Laparoscopic Radical Prostatectomy (RS-RARP), which spares the retropubic space by passing through the pouch of Douglas avoiding bladder mobilization and preserving the endopelvic fascia, the Santorini’s plexus and the puboprostatic ligaments, drastically reducing urinary incontinence onset. There are various surgical approaches used in RARP and these techniques primarily depend on the surgical anatomy of the periprostatic fascias. The connection between the lateral pelvic fascia and the prostate capsule determines the localization of NVB. The intrafascial plane refers to the space included between the prostate capsule and the prostatic fascia. The interfascial plane is the space between the prostatic fascia and the lateral pelvic fascia. Before initiating dissection in the intrafascial or interfascial planes, the endopelvic fascia must be incised along the tendinous arch of the pelvic fascia. The extrafascial plane involves the outer part of the NVB and is a non-nerve-sparing technique. Therefore, a nerve sparing technique can be achieved through either interfascial or intrafascial dissection [23]. The Pasadena consensus panel proposed a different terminology for the dissection planes to clarify the level of nerve preservation and it helps to differentiate and describe the extent of nerve preservation in each respective dissection plane. They suggested using the terms full nerve-sparing for intrafascial dissection, partial nerve-sparing for interfascial dissection, and minimal nerve-sparing for subextrafascial [24].

Radical prostatectomy side effects

Urinary incontinence (UI) is one of the most common complications after RP. It has a complex etiology that can be caused by bladder or sphincter dysfunction, or a combination of the two. Although pre-existing bladder changes may affect UI after RP, sphincter dysfunction caused by tissue injury associated with prostate dissection is thought to be the most significant cause. Moreover, RP reduces the length and maximal closure pressure of the urethra. Another common side effect after RP is erectile dysfunction (ED) (still 10–46% cases), albeit with a decreasing trend of its frequency thanks to the increasing use of the nerve sparing approaches [25].

Prostate MRI assessment

PI-RADS score and Image quality

Prostate MRI should be acquired and reported according to the recommendations from PI-RADS v2.1, a scoring system designed to improve the detection, localization, characterization, and risk stratification in patients with suspected PCa [5, 12, 26]. However, prostate MRI, being technically demanding, must be acquired with high image quality standards, in order to reach its full diagnostic power [27, 28]. With the introduction of PI-QUAL score (Prostate Imaging Quality) a new standardized assessment of MRI scans quality has been achieved [29].

According to PI-RADS v2.1 the acquisition protocol includes T2-weighted imaging (T2WI) on the axial plane and on at least an orthogonal plane (coronal or sagittal plane), diffusion-weighted imaging (DWI) obtained with low b-value (preferentially 50–100 s/mm2), intermediate ones (800–1000 s/mm2) and high one (≥ 1400 s/mm2), with apparent diffusion coefficient (ADC) map reconstructions, built on at least 3 b values < 1000. Dynamic-contrast enhanced (DCE) images after intravenous contrast injection should be acquired too (Table 3) [12, 30, 31].Table 3 Parameters of the magnetic resonance imaging protocol according to PI-RADS v2.1 recommendations, using both 3 T and 1.5 T scanners

Sequence	
T2WI	FOV (cm)	12–20	
Slice thickness (mm)	3	
In plane dimension (mm x mm)	 ≤ 0.7 x ≤ 0.4	
DWI	FOV (cm)	16–22	
Slice thickness (mm)	 ≤ 4	
TE (msec)	 ≤ 90	
TR (msec)	 ≥ 3000	
In plane dimension (mm)	 ≤ 2.5	
b-value (sec/mm2)	0–100; 800–100; ≥ 1400	
DCE	FOV	Including both the entire prostate and seminal vesicles	
Temporal resolution (s)	 < 15	
Slice thickness (mm)	3	
TE (msec)	 < 5	
TR (msec)	 < 100	
In plane dimension (mm x mm)	 ≤ 2 x ≤ 2	
Temporal resolution (s)	 ≤ 15	
PI-RADS, Prostate Imaging Reporting and Data System; T2WI, T2-Weghited Images; FOV, Field of View; DWI, Diffusion-Weighted Imaging; TE, Time of Echo; TR, Time of Repetition; DCE, Dynamic Contrast-Enhanced

MRI techniques not included in the PI-RADS system

Diffusion tensor imaging (DTI) and tractography have evolved as noninvasive imaging techniques that provide in vivo information on fiber anatomy by providing a three-dimension (3D) visualization. The method is based on the sensitivity of water protons observed in the microstructural environment [32, 33]. According to fiber myelination, axonal membrane, and sub-voxel coherence, the diffusion pathways of water molecules follow the longitudinal axis of myelinated fibers rather than the perpendicular one. Furthermore, direction-dependent diffusion may be inferred by using diffusion sensitizing gradients in distinct directions [33, 34]. This data is represented in diffusion tensor maps, which furnish insights into the underlying tissue's microstructure and properties. Therefore, the macroscopic diffusion data may be used to elicit qualitative changes in fiber diameter and extracellular fraction, while rigorous diffusion modeling can yield quantitative values for these parameters. In addition to information on microstructure analyzed, DT can be used to evaluate tissue architecture, such as fiber length and density [32]. This technology can be used to map periprostatic nerve fibers, to recognize the entire neurovascular bundle and to locate it, giving important information before RP. DTI can be used also to detect sphincters and membranous urethra fibers, which present circular and longitudinal fibers, respectively. Indeed, thanks to quantitative DTI it is feasible to differentiate this kind of different fibers [8, 32, 35]. However, DTI is strongly influenced by image quality, suffering artifacts [33, 36].

What to look for on MR images before surgery to avoid complications

Description and measurements of anatomical features on preoperative prostate MRI are employed in risk models for treatment decisions to predict predisposing factors of the most common side effects and minimize positive RP margins [37]. Most of these adverse effects are debilitating and affect the quality of life of patients. Therefore, it is crucial to identify in MR images the structures involved in generating process of these side effects, to prevent or reduce their severity.

Structures involved in urinary incontinence

Urethra should be assessed on MRI, evaluating its length (LP) and width (WP). Prostate volume (PV) should also be calculated, using the formula for calculating the volume of an ellipsoid [38]. Other findings to be considered are membranous urethral length (MUL), urethral wall thickness (UWT), elevator ani muscle (LAM) and obturator internus muscle (OIM) thickness, ratio of elevator ani muscle/prostate volume (LAM/PV), urethra maximal diameter, and prostate-urethral angle. In particular, MUL and PV proved to be involved in UI [7, 39–41]. MUL is typically measured on sagittal or coronal T2-weighted images [42] and recent meta-analyses indicate that a longer MUL measurement based on MRI [37, 43] is linked to a higher likelihood of achieving continence restoration [43]. Moreover, MUL assessment may also be useful in identifying the best candidates for preoperative pelvic floor muscle workouts, which have been found to enhance early postoperative continence [44]. Indeed, the pre-surgery measurement of the MUL on MRI images proved to be an independent predictor of urinary continence after prostatectomy. [45]. Boellaard et al. [46] proposed new standardized recommendations to correctly measure MUL on MRI. More specifically, they suggest evaluating it in sagittal T2WI since coronal images typically lack parallel angulation to the MU and to identify the hyperintense urethral lumen and dorsal hypointense membranous structure on one of the midsagittal images. The measurement line should be placed dorsally and parallel to the hyperintense urethral lumen. The upper limit should be the prostate apex, defined as the lowest portion of the peripheral zone of the dorsal prostate; the lower limit should be considered the intersection of the urethra with the bulb of the corpus spongiosum as the landmark. Therefore, MRI MUL measurement should be included in a pre-treatment predictive model alongside other major indicators of UI, such as patient age, BMI, comorbidities profile, preoperative urinary and erectile dysfunction (Fig. 1).Fig. 1 T2WI on coronal plane (a, b) and sagittal plane (c) where is evident the MUL. The white line indicates the correct measurement of MUL, showing how the sagittal plane is more appropriate. T2WI, T2 weighted imaging; MUL, membranous urethral length

Another important structure involved in UI is the urethral sphincter complex. The urethral sphincter complex comprises a cylindrical structure that encircles the urethra, extending vertically from the bladder neck to the perineal membrane. It is composed by the proximal lissosphincter, a smooth muscle and the distal rhabdosphincter, a skeletal muscle [47]. The urethral striated sphincter forms a covering over the anteriolateral urethra, resembling a hat from the bladder neck to the verumontanum. It transitions into a ring shape around the urethra from the verumontanum to the perineal membrane, culminating at the central tendon of the perineum. Moving from the bladder neck to the perineal membrane, the thickness of the urethral smooth sphincter gradually decreases, extending forward to encircle the urethra alongside the urethral striated sphincter in a ring-like fashion [47, 48]. In particular the lissosphincter muscle has been indicated as a critical structure for continence maintenance [32]. MRI enables the identification of sphincter complex as hypointense structure on T2W images. Because the muscle bundles of the posterior urethral sphincter exhibit low signal intensity on T2W images, they sharply contrast with the high signal intensity of the urethral mucosa, submucosa, and surrounding fat-containing tissues, thereby allowing for clear visualization of their contour, starting, and ending points [48]. In addiction DTI allow to detect urethral sphincter complex fibers, by providing 3D visualization of the urethral sphincter complex fibers in terms of size, location, direction, and integrity [35].

Finally, another important MRI finding to be detected and described is the presence of a prostate median lobe: the distortion of bladder neck during RP can be due to a protruded median lobe. A large median lobe can lead to an obstruction that impairs the smooth flow of urine at the bladder neck and alters the normal angle between prostate and urethra, causing abnormal bladder contractions during urination. The median lobe makes difficult to clearly see the posterior border of the prostate and bladder neck and can hinder the identification of ureters ostiums (Fig. 2). In case of bladder neck resection, the risk of injuring the ureteral orifices due to their proximity to the edge of the bladder neck becomes higher [49].Fig. 2 T2 weighted imaging on coronal (a) and axial (b) plane in which is evident a median lobe obstructing both ureteral ostiums, hindering their identification; consequent distal ureteral distension is detected (white arrows)

Structures involved in erectile dysfunction

The neurovascular bundle (NVB) crosses extremely close to the prostate gland and carries blood flow as well as sympathetic and parasympathetic neural branches to the corpora cavernosa and the external urinary sphincter muscle, playing a key role in penile erection and urine continence. Approximately 52% of nerves are distributed along the lateral surface of the prostate, while the remaining 48% forms a distinct bundle in the posterior-lateral region [50]. One possible side effect during RP is the neurapraxia, due to the traction of periprostatic neurovascular fibers, during the dissection of the gland. The drafting of standardize nomograms to predict ED after RP have been largely proposed, without significant results [22, 51]. The NVB has low signal intensity on T1-and T2-WI and it is surrounded by a fat plane with characteristic high signal intensity [52] (Fig. 3). MRI and DTI could be used to locate the NVB and periprostatic neurovascular fibers (PNF) to furnish key pre-treatment information for surgery planning, to prevent UI and ED (Fig. 4).Fig. 3 Example of T2 weighted imaging on axial plane where is visible the neurovascular bundle (white arrow head)

Fig. 4 a T2WI (axial) shows two alterations respectively on the left lateral mid peripheral zone (white arrow head), which determines capsular bulging and on the right mid antero-lateral peripheral zone (white arrow head); b, c DWI (b = 2000) and ADC map show a focal and marked hyperintensity on high b-value and focal hypointensity on ADC map on the left lateral peripheral zone lesion (white arrow head), with capsular bulging. d DTI reveals that the lesion is distant from the NVB (white arrows). T2WI, T2 weighted imaging; DWI, Diffusion Weighted Imaging; ADC map, Apparent Diffusion Coefficient map; DTI, Diffusion Tensor Imaging; NVB, neurovascular bundle

Extra-prostatic extension and surgical margins

To date MRI is used to detect and localize suspected prostate cancer and also to guide biopsies [53, 54]. However, MRI has a potential role for local preoperative staging and the identification of extra-prostatic extension and the infiltration of the nearby anatomical structures (i.e., bladder neck and rectum), features that carries the patient to an higher stage and to a worse prognosis, due to an higher risk of positive margins after RP and therefore a greater incidence of recurrence [55, 56]. Indeed, extra-prostatic extension (EPE) (T3a and T3b) in PCa is linked to an increased risk of biochemical recurrence and metastatic disease after RP or radiation therapy [57]. Several MRI features are associated with pathological EPE such as tumor size and volume, the length of tumor contact with the capsule (Fig. 5), capsular tumor’s bulging (Fig. 6), fat tissue infiltration and seminal vesicles invasion (Fig. 7), that could be easily identified on a T2W imaging and on functional imaging (DWI and DCE) [54, 58]. In particular, a greater length of PCa contact with the capsule on histopathology correlates with higher probability of EPE; therefore, it represents an independent predictor for EPE detection. Prostate MRI demonstrated moderate sensitivity and high specificity to detect extra-capsular extension, seminal vesicle involvement or T3 stage [13]. The definition of seminal vesicles involvement is essential, and Martini et al. [59] proposed a new nomogram, including MRI evaluation of seminal vesicles infiltration, with promising results in the setting of risk-stratification of patients who can be directed to nerve sparing RP.Fig. 5 a T2WI on axial plane shows an alteration on the mid left posterior-lateral peripheral zone (white arrow head); b, c DWI (b = 2000) and ADC map show a focal and marked  hyperintensity on high b value and hypointensity on ADC map on the left peripheral zone lesion (white arrow head); d DCE shows an early and focal enhancement of the lesion. All the sequences demonstrate a lesion contact with the capsule measuring about 15 mm. T2WI, T2 weighted imaging; DWI, Diffusion Weighted Imaging; ADC, Apparent Diffusion Coefficient; DCE, dynamic contrast enhancement

Fig. 6 a, e T2WI (axial and coronal plane) show an alteration on the mid right posterior-lateral peripheral zone (white arrow head), distant from the NVB; b, c DWI (b = 2000) and ADC map show a focal and marked hyperintensity on high b value and hypointensity on ADC map on the right posterior lateral peripheral zone lesion (white arrow head); d DCE shows an early and focal enhancement of the lesion. All the sequences demonstrate marked capsular bulging. T2WI, T2 weighted imaging; DWI, Diffusion Weighted Imaging; ADC map, Apparent Diffusion Coefficient; NVB, neurovascular bundle; DCE, dynamic contrast enhancement

Fig. 7 a T2WI (axial plane) shows an alteration on the right mid-base peripheral and transitional zone (white arrow head); b, c DWI (b = 2000) and ADC map show a focal and marked hyperintensity on high b value and hypointensity on ADC map on the right mid-base zone (white arrow head); d DCE shows early and focal enhancement of the lesion. All the sequences demonstrate the infiltration of the right seminal vesicle. T2WI, T2 weighted imaging; DWI, Diffusion Weighted Imaging; ADC map, Apparent Diffusion Coefficient; DCE, dynamic contrast enhancement

Prostate apex description

Achieving sufficient urethral length after RP can be challenging in case of prostate apical prominence [60]. Indeed, Lee et al. [60] proposed a new classification of prostatic apex shape on MR images: type A defined as a prostatic apex overlapping the membranous urethra both anteriorly and posteriorly; type B and C only anteriorly or posteriorly, respectively; type D with no signs of overlapping. The last group proved to be linked to an higher rate of early return to urinary continence. Furthermore, a more recent experience too proved how type C and D were associated to very early continence restoration after catheter removal following RP [61]. Moreover, the prostate apex can be close to the skeletal fibers of the urogenital diaphragm, and therefore apical lesions should be precisely described because they might involve these structures. Indeed, in prostatectomy specimens, positive apical margins can be found, with cancerous cells reaching the skeletal muscle [62].

Lymph-nodes involvement

For patients with non-metastatic PCa undergoing RP, European Association of Urology guidelines [5] suggest considering an ePLND for high- and intermediate-risk cases exploiting validated nomograms, such as the Briganti [63], the Gandaglia [64] or the Memorial Sloan Kettering Cancer Center [65] nomograms. However, imaging, and more specifically MRI, proved to play an important role in nodal assessment and Node-RADS score has been proposed [66]. It can be applied to any anatomical site, aiming to standardize the reporting, exploiting dimension and configuration criteria to assign a 5-point category score, to define the likelihood of nodal involvement. Node-RADS score applied to the specific pre-RP evaluation proved a very high specificity, suggesting its potential role in addition to the already mentioned nomograms [3].

Discussion

Since prostate cancer is a highly incident disease, with an increasing number of possible surgical approaches, it is necessary to standardize preoperative assessment to minimize long-term side effect and consequently improve patients’ quality of life. When reading an MRI, especially if positive for PCa, it is mandatory to precisely describe all the anatomical structures involved in possible RP side effects and all the extra-prostatic structures eventually infiltrated. It would be important to describe all these elements in structured radiological reports (Fig. 8), to precisely furnish all the information that are useful for the pre-surgery planning. This standardized MR approach could help urologists to have a clearer view of the local stage of the neoplasm, to consequently choose the most appropriate surgical technique.Fig. 8 Example of a pre-radical prostatectomy magnetic resonance imaging structured report

Complications occur in 10–25% of patients who undergo RP; age, pre-treatment PSA value, patient comorbidities, body mass index, and surgeon experience are independent clinical risk factors for side effects [42]. When compared to open prostatectomy, robot-assisted approach has the benefits of a minimally invasive procedure, with less intraoperative blood loss, less post-surgery pain, and a shorter hospitalization time. Prostate size is associated to greater complexity of surgical procedures [42]. Mazzone et al. proposed an updated super-extended RARP technique, which is suitable for patients with posterior iT3a or iT3b as indicated in preoperative MRI [67]. This technique proves to be effective in managing locally advanced stage cases, showing favorable outcomes in terms of reduced complications and successful recovery of urinary continence [67]. Additionally, this technique may offer a promising possibility of achieving biochemical disease control and potentially delaying disease progression for low-grade tumors and negative surgical margins at the final pathology [67].

Understanding pelvic anatomy is critical for protecting functioning structures affecting continence recovery during surgery. The integrity of the distal sphincteric unit determines bladder control following RP. Sphincter muscle preparation, rhabdosphincter restoration, and sphincter-preserving anastomotic procedures are all key elements for maintaining functioning tissue. Therefore a correct radiological pre-surgical identification of this anatomical structures is crucial to prevent UI [42].

It became evident that MRI, with possible acquisition of additional DTI technique, improves the accuracy of the surgical planning also with regard to the appropriateness of preserving or resecting NVBs and sphincter fibers complex [11, 68]. Therefore the use of validated preoperative tools, including MRI features, for predicting EPE of prostate tumor could assist the urologist to correctly stratify patients for surgical planning and determine a reduction of adverse outcomes [69, 70]. Pesapane et al. reported [71] that a staging MRI should be used to either rule out EPE (when the cancer does not touch the prostatic capsule) or to predict the likelihood of EPE. Nomograms using preoperative PSA, clinical stage, and biopsy Gleason score (i.e., Partin tables) can already be used to extract such information. These provide the likelihood of EPE but do not provide other essential information, such as its amount and precise location. Both can be provided by MRI staging, either as a stand-alone test or in conjunction with PSA and/or other clinical variables. In the literature, nomograms which include MRI have been developed for these purposes; Soeterik T. et al. proposed three models outperforming nomogram without MRI as staging tool [72]. Furthemore, Martini et al. [73] developed a practical nomogram that could have broader applicability in daily medical practice to predict the risk of EPE, which has been validated too [74]. This nomogram incorporates various factors, including serum PSA level, highest ISUP grade, and the highest percentage of tumor involvement in biopsy cores, in addition to MRI findings [74]. Russo et al. [75], following the local staging system proposed by Wheeler, suggested a pre-surgical staging system based on mp-MRI (radiological Wheeler), resulting in a more precise surgical technique, selecting the degree of nerve sparing approach (Table 4). The accuracy of the proposed staging system resulted to be high, therefore mpMRI is a critical investigating tool for preoperative local staging. The key role of MRI for preoperative assessment was endorsed by Schiavina et al. too, affirming that the incidence of positive surgical margins was considerably lower in patients with a preoperative mpMRI compared to those without preoperative mpMRI (respectively 12.4% vs. 24.1%) [50].Table 4 Radiological Wheeler classification of prostate cancer using magnetic resonance imaging

Organ-confined	
Radiological Wheeler Class	Description	
L0	Tumor does not touch the capsule	
L1	Tumor present minimal contact with the capsule without capsule alteration	
L2	Broad contact between tumor and the capsule and/or bulging and/or inhomogeneity of capsule	
Non organ-confined	
Radiological Wheeler Class	Description	
L3	Tumor invades peri-visceral adipose tissue or balder neck smooth muscle	
L3 focal	Slight irregularity of margin of the capsule	
L3 extended	Discontinuity of capsule with periprostatic adipose tissue inhomogeneity or seminal vesicles infiltration	

Limitations

Unfortunately MRI criteria already in use are mostly qualitative, and still associated with an high degree of reader variability, even if PI-RADS v2.1 scoring system achieve an higher reproducibility in this setting too [54].

Moreover, even if MRI has become the gold standard for the diagnosis of PCa, it has some limitations. DWI, ADC map and DCE sequences are strongly susceptible to motion artifact, which would lead to low quality images [76]. The quality is also influenced by the presence of foreign metallic bodies (such as hip prothesis) or intrinsic patient characteristics (such as severe obesity). In this case the thickness of the adipose tissue determines an increase distance between the coil and the prostate gland, resulting in an images' deterioration, with a low-quality exams [76].

Conclusions

MRI is recommended as first line test for prostate cancer early detection, but it could also significantly aid urologists in their preoperative planning. With this goal, MRI readers should describe in a standardized scheme all the anatomical structures pertaining the prostate gland and prostatic bed, to furnish to surgeons essential information that would lead to a precise pre-radical prostatectomy planning, with consequent reduction of side effects.

Acknowledgements

The research leading to this review was supported by the projects PNRR- 4 (CUP B53C22004000006) Funded by the European Union - Next Generation EU through the Italian Ministry of University and Research.

Author Contributions

All authors contributed to the review conception, design and revision.

Funding

Open access funding provided by Università degli Studi di Roma La Sapienza within the CRUI-CARE Agreement.

Declarations

Conflict of interest

The authors declare that they have no conflict of interest

Ethical approval

This review does not involve human participants, therefore no informed consent was needed.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Pecoraro M Messina E Bicchetti M The future direction of imaging in prostate cancer: MRI with or without contrast injection Andrology 2021 10.1111/andr.13041 34889528
Pecoraro M, Messina E, Bicchetti M et al (2021) The future direction of imaging in prostate cancer: MRI with or without contrast injection. Andrology. 10.1111/andr.1304134889528 10.1111/andr.13041
2. Wilt TJ Jones KM Barry MJ Follow-up of prostatectomy versus observation for early prostate cancer N Engl J Med 2017 377 132 142 10.1056/NEJMoa1615869 28700844
Wilt TJ, Jones KM, Barry MJ et al (2017) Follow-up of prostatectomy versus observation for early prostate cancer. N Engl J Med 377:132–142. 10.1056/NEJMoa161586928700844 10.1056/NEJMoa1615869
3. Lucciola S Pisciotti ML Frisenda M Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms Prostate Cancer Prostatic Dis 2023 26 379 387 10.1038/s41391-022-00564-z 35732820
Lucciola S, Pisciotti ML, Frisenda M et al (2023) Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms. Prostate Cancer Prostatic Dis 26:379–387. 10.1038/s41391-022-00564-z35732820 10.1038/s41391-022-00564-z
4. Panebianco V Villeirs G Weinreb JC Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international consensus -based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy Eur Urol Oncol 2021 4 868 876 10.1016/j.euo.2021.01.003 33582104
Panebianco V, Villeirs G, Weinreb JC et al (2021) Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international consensus -based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy. Eur Urol Oncol 4:868–876. 10.1016/j.euo.2021.01.00333582104 10.1016/j.euo.2021.01.003
5. Mottet N, Cornford P, van den Bergh RCN, et al. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.
6. Rahnama’i MS, Marcelissen T, Geavlete B, Current management of post-radical prostatectomy urinary incontinence Front Surg 2021 8 647656 10.3389/fsurg.2021.647656 33898508
Rahnama’i MS, Marcelissen T, Geavlete B, et al (2021) Current management of post-radical prostatectomy urinary incontinence. Front Surg 8:647656. 10.3389/fsurg.2021.64765633898508 10.3389/fsurg.2021.647656
7. Lima TFN Bitran J Frech FS Ramasamy R Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities Int J Impot Res 2021 33 401 409 10.1038/s41443-020-00374-8 33204007
Lima TFN, Bitran J, Frech FS, Ramasamy R (2021) Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities. Int J Impot Res 33:401–409. 10.1038/s41443-020-00374-833204007 10.1038/s41443-020-00374-8
8. Panebianco V Sciarra A Marcantonio A Conventional imaging and multiparametric magnetic resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer Q J Nucl Med Mol Imaging 2012 56 331 342 23013663
Panebianco V, Sciarra A, Marcantonio A et al (2012) Conventional imaging and multiparametric magnetic resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer. Q J Nucl Med Mol Imaging 56:331–34223013663
9. Messina E La Torre G Pecoraro M Design of a magnetic resonance imaging-based screening program for early diagnosis of prostate cancer: preliminary results of a randomized controlled trial—Prostate Cancer Secondary Screening in Sapienza (PROSA) Eur Radiol 2023 10.1007/s00330-023-10019-1 37561183
Messina E, La Torre G, Pecoraro M et al (2023) Design of a magnetic resonance imaging-based screening program for early diagnosis of prostate cancer: preliminary results of a randomized controlled trial—Prostate Cancer Secondary Screening in Sapienza (PROSA). Eur Radiol. 10.1007/s00330-023-10019-137561183 10.1007/s00330-023-10019-1
10. Picchio M Mapelli P Panebianco V Imaging biomarkers in prostate cancer: role of PET/CT and MRI Eur J Nucl Med Mol Imaging 2015 42 644 655 10.1007/s00259-014-2982-5 25595344
Picchio M, Mapelli P, Panebianco V et al (2015) Imaging biomarkers in prostate cancer: role of PET/CT and MRI. Eur J Nucl Med Mol Imaging 42:644–655. 10.1007/s00259-014-2982-525595344 10.1007/s00259-014-2982-5
11. Giganti F Rosenkrantz AB Villeirs G The evolution of MRI of the prostate: the past, the present, and the future Am J Roentgenol 2019 213 384 396 10.2214/AJR.18.20796 31039022
Giganti F, Rosenkrantz AB, Villeirs G et al (2019) The evolution of MRI of the prostate: the past, the present, and the future. Am J Roentgenol 213:384–396. 10.2214/AJR.18.2079631039022 10.2214/AJR.18.20796
12. Turkbey B Rosenkrantz AB Haider MA Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2 Eur Urol 2019 76 340 351 10.1016/j.eururo.2019.02.033 30898406
Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76:340–351. 10.1016/j.eururo.2019.02.03330898406 10.1016/j.eururo.2019.02.033
13. Marenco J Orczyk C Collins T Role of MRI in planning radical prostatectomy: What is the added value? World J Urol 2019 37 1289 1292 10.1007/s00345-019-02762-2 30993425
Marenco J, Orczyk C, Collins T et al (2019) Role of MRI in planning radical prostatectomy: What is the added value? World J Urol 37:1289–1292. 10.1007/s00345-019-02762-230993425 10.1007/s00345-019-02762-2
14. McNeal JE The zonal anatomy of the prostate Prostate 1981 2 35 49 10.1002/pros.2990020105 7279811
McNeal JE (1981) The zonal anatomy of the prostate. Prostate 2:35–49. 10.1002/pros.29900201057279811 10.1002/pros.2990020105
15. Humphrey PA Histopathology of prostate cancer Cold Spring Harb Perspect Med 2017 7 a030411 10.1101/cshperspect.a030411 28389514
Humphrey PA (2017) Histopathology of prostate cancer. Cold Spring Harb Perspect Med 7:a030411. 10.1101/cshperspect.a03041128389514 10.1101/cshperspect.a030411
16. Viliers A Steg A Boccon-Gibod L Anatomy of the prostate: review of the different models Eur Urol 1991 20 261 268 10.1159/000471714 1726083
Viliers A, Steg A, Boccon-Gibod L (1991) Anatomy of the prostate: review of the different models. Eur Urol 20:261–268. 10.1159/0004717141726083 10.1159/000471714
17. da Silva MC Pecoraro M Pisciotti ML The learning curve in bladder MRI using VI-RADS assessment score during an interactive dedicated training program Eur Radiol 2022 10.1007/s00330-022-08766-8 35366122
da Silva MC, Pecoraro M, Pisciotti ML et al (2022) The learning curve in bladder MRI using VI-RADS assessment score during an interactive dedicated training program. Eur Radiol. 10.1007/s00330-022-08766-835366122 10.1007/s00330-022-08766-8
18. McNeal JE Normal histology of the prostate Am J Surg Pathol 1988 12 619 633 10.1097/00000478-198808000-00003 2456702
McNeal JE (1988) Normal histology of the prostate. Am J Surg Pathol 12:619–633. 10.1097/00000478-198808000-000032456702 10.1097/00000478-198808000-00003
19. Walz J Graefen M Huland H Basic principles of anatomy for optimal surgical treatment of prostate cancer World J Urol 2007 25 31 38 10.1007/s00345-007-0159-6 17333199
Walz J, Graefen M, Huland H (2007) Basic principles of anatomy for optimal surgical treatment of prostate cancer. World J Urol 25:31–38. 10.1007/s00345-007-0159-617333199 10.1007/s00345-007-0159-6
20. Panebianco V Grazhdani H Iafrate F 3D CT protocol in the assessment of the esophageal neoplastic lesions: Can it improve TNM staging? Eur Radiol 2006 16 414 421 10.1007/s00330-005-2851-5 16041528
Panebianco V, Grazhdani H, Iafrate F et al (2006) 3D CT protocol in the assessment of the esophageal neoplastic lesions: Can it improve TNM staging? Eur Radiol 16:414–421. 10.1007/s00330-005-2851-516041528 10.1007/s00330-005-2851-5
21. Cooperberg MR Pasta DJ Elkin EP The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy J Urol 2005 173 1938 1942 10.1097/01.ju.0000158155.33890.e7 15879786
Cooperberg MR, Pasta DJ, Elkin EP et al (2005) The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 173:1938–1942. 10.1097/01.ju.0000158155.33890.e715879786 10.1097/01.ju.0000158155.33890.e7
22. Vis AN Bergh RCN Poel HG Selection of patients for nerve sparing surgery in robot-assisted radical prostatectomy BJUI Compass 2022 3 6 18 10.1002/bco2.115 35475150
Vis AN, Bergh RCN, Poel HG et al (2022) Selection of patients for nerve sparing surgery in robot-assisted radical prostatectomy. BJUI Compass 3:6–18. 10.1002/bco2.11535475150 10.1002/bco2.115
23. Tavukçu HH Aytac O Atug F Nerve-sparing techniques and results in robot-assisted radical prostatectomy Investig Clin Urol 2016 57 S172 10.4111/icu.2016.57.S2.S172 27995221
Tavukçu HH, Aytac O, Atug F (2016) Nerve-sparing techniques and results in robot-assisted radical prostatectomy. Investig Clin Urol 57:S172. 10.4111/icu.2016.57.S2.S17227995221 10.4111/icu.2016.57.S2.S172
24. Montorsi F Wilson TG Rosen RC Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena consensus panel Eur Urol 2012 62 368 381 10.1016/j.eururo.2012.05.057 22763081
Montorsi F, Wilson TG, Rosen RC et al (2012) Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena consensus panel. Eur Urol 62:368–381. 10.1016/j.eururo.2012.05.05722763081 10.1016/j.eururo.2012.05.057
25. Schmid FA Poyet C Rizzi G Dynamic contrast enhancement in prostate MRI as predictor of erectile function and recovery after radical prostatectomy Aging Male 2020 23 1518 1526 10.1080/13685538.2020.1815695 33252281
Schmid FA, Poyet C, Rizzi G et al (2020) Dynamic contrast enhancement in prostate MRI as predictor of erectile function and recovery after radical prostatectomy. Aging Male 23:1518–1526. 10.1080/13685538.2020.181569533252281 10.1080/13685538.2020.1815695
26. Falagario UG Lantz A Jambor I Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors World J Urol 2023 41 2967 2974 10.1007/s00345-023-04634-2 37787941
Falagario UG, Lantz A, Jambor I et al (2023) Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors. World J Urol 41:2967–2974. 10.1007/s00345-023-04634-237787941 10.1007/s00345-023-04634-2
27. Cipollari S Guarrasi V Pecoraro M Convolutional neural networks for automated classification of prostate multiparametric magnetic resonance imaging based on image quality Magn Reson Imaging 2022 55 480 490 10.1002/jmri.27879
Cipollari S, Guarrasi V, Pecoraro M et al (2022) Convolutional neural networks for automated classification of prostate multiparametric magnetic resonance imaging based on image quality. Magn Reson Imaging 55:480–490. 10.1002/jmri.2787910.1002/jmri.27879
28. Messina E Pecoraro M Laschena L Low cancer yield in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: Is it time to reconsider scoring categorization? Eur Radiol 2023 10.1007/s00330-023-09605-0 37561183
Messina E, Pecoraro M, Laschena L et al (2023) Low cancer yield in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: Is it time to reconsider scoring categorization? Eur Radiol. 10.1007/s00330-023-09605-037561183 10.1007/s00330-023-09605-0
29. Giganti F Allen C Emberton M Prostate imaging quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial Eur Urol Oncol 2020 3 615 619 10.1016/j.euo.2020.06.007 32646850
Giganti F, Allen C, Emberton M et al (2020) Prostate imaging quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial. Eur Urol Oncol 3:615–619. 10.1016/j.euo.2020.06.00732646850 10.1016/j.euo.2020.06.007
30. Cipollari S Pecoraro M Forookhi A Biparametric prostate MRI: impact of a deep learning-based software and of quantitative ADC values on the inter-reader agreement of experienced and inexperienced readers Radiol med 2022 127 1245 1253 10.1007/s11547-022-01555-9 36114928
Cipollari S, Pecoraro M, Forookhi A et al (2022) Biparametric prostate MRI: impact of a deep learning-based software and of quantitative ADC values on the inter-reader agreement of experienced and inexperienced readers. Radiol med 127:1245–1253. 10.1007/s11547-022-01555-936114928 10.1007/s11547-022-01555-9
31. Sciarra A Panebianco V Ciccariello M Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer Cancer Invest 2010 28 424 432 10.3109/07357900903287048 20073578
Sciarra A, Panebianco V, Ciccariello M et al (2010) Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer. Cancer Invest 28:424–432. 10.3109/0735790090328704820073578 10.3109/07357900903287048
32. Sinha S Sinha U Malis V Exploration of male urethral sphincter complex using diffusion tensor imaging (DTI)-based fiber-tracking J Magn Reson Imaging 2018 48 1002 1011 10.1002/jmri.26017 29573022
Sinha S, Sinha U, Malis V et al (2018) Exploration of male urethral sphincter complex using diffusion tensor imaging (DTI)-based fiber-tracking. J Magn Reson Imaging 48:1002–1011. 10.1002/jmri.2601729573022 10.1002/jmri.26017
33. Panebianco V Barchetti F Sciarra A In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR Diffusion Tensor Imaging Eur J Radiol 2013 82 1677 1682 10.1016/j.ejrad.2013.05.013 23773553
Panebianco V, Barchetti F, Sciarra A et al (2013) In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR Diffusion Tensor Imaging. Eur J Radiol 82:1677–1682. 10.1016/j.ejrad.2013.05.01323773553 10.1016/j.ejrad.2013.05.013
34. Pavone P Laghi A Panebianco V MR cholangiography: techniques and clinical applications Eur Radiol 1998 8 901 910 10.1007/s003300050486 9683691
Pavone P, Laghi A, Panebianco V et al (1998) MR cholangiography: techniques and clinical applications. Eur Radiol 8:901–910. 10.1007/s0033000504869683691 10.1007/s003300050486
35. Verde ASC Santinha J Carrasquinha E Diffusion tensor-based fiber tracking of the male urethral sphincter complex in patients undergoing radical prostatectomy: a feasibility study Insights Imaging 2020 11 126 10.1186/s13244-020-00927-x 33245443
Verde ASC, Santinha J, Carrasquinha E et al (2020) Diffusion tensor-based fiber tracking of the male urethral sphincter complex in patients undergoing radical prostatectomy: a feasibility study. Insights Imaging 11:126. 10.1186/s13244-020-00927-x33245443 10.1186/s13244-020-00927-x
36. Panebianco V De Berardinis E Barchetti G An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer Eur Radiol 2017 27 3759 3766 10.1007/s00330-017-4758-3 28181054
Panebianco V, De Berardinis E, Barchetti G et al (2017) An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer. Eur Radiol 27:3759–3766. 10.1007/s00330-017-4758-328181054 10.1007/s00330-017-4758-3
37. Van Dijk-de Haan MC Boellaard TN Tissier R Value of different magnetic resonance imaging-based measurements of anatomical structures on preoperative prostate imaging in predicting urinary continence after radical prostatectomy in men with prostate cancer: a systematic review and meta-analysis Eur Urol Focus 2022 8 1211 1225 10.1016/j.euf.2022.01.015 35181284
Van Dijk-de Haan MC, Boellaard TN, Tissier R et al (2022) Value of different magnetic resonance imaging-based measurements of anatomical structures on preoperative prostate imaging in predicting urinary continence after radical prostatectomy in men with prostate cancer: a systematic review and meta-analysis. Eur Urol Focus 8:1211–1225. 10.1016/j.euf.2022.01.01535181284 10.1016/j.euf.2022.01.015
38. Garvey B Turkbey B Truong H Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia Diagn Interv Radiol 2014 20 229 233 10.5152/dir.2014.13322 24675166
Garvey B, Turkbey B, Truong H et al (2014) Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia. Diagn Interv Radiol 20:229–233. 10.5152/dir.2014.1332224675166 10.5152/dir.2014.13322
39. Tienza A Hevia M Benito A MRI factors to predict urinary incontinence after retropubic/laparoscopic radical prostatectomy Int Urol Nephrol 2015 47 1343 1349 10.1007/s11255-015-1019-8 26049974
Tienza A, Hevia M, Benito A et al (2015) MRI factors to predict urinary incontinence after retropubic/laparoscopic radical prostatectomy. Int Urol Nephrol 47:1343–1349. 10.1007/s11255-015-1019-826049974 10.1007/s11255-015-1019-8
40. Hudolin T (2022) Pelvic Rehabilitation for Urinary Incontinence after Radical Prostatectomy. ACC. 10.20471/acc.2022.61.s3.10
41. Sciarra A Panebianco V Cattarino S Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy BJU Int 2012 110 1661 1665 10.1111/j.1464-410X.2012.11146.x 22564540
Sciarra A, Panebianco V, Cattarino S et al (2012) Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy. BJU Int 110:1661–1665. 10.1111/j.1464-410X.2012.11146.x22564540 10.1111/j.1464-410X.2012.11146.x
42. McEvoy SH Raeside MC Chaim J Preoperative prostate MRI: a road map for surgery Am J Roentgenol 2018 211 383 391 10.2214/AJR.17.18757 29894214
McEvoy SH, Raeside MC, Chaim J et al (2018) Preoperative prostate MRI: a road map for surgery. Am J Roentgenol 211:383–391. 10.2214/AJR.17.1875729894214 10.2214/AJR.17.18757
43. Mungovan SF Sandhu JS Akin O Preoperative membranous urethral length measurement and continence recovery following radical prostatectomy: a systematic review and meta-analysis Eur Urol 2017 71 368 378 10.1016/j.eururo.2016.06.023 27394644
Mungovan SF, Sandhu JS, Akin O et al (2017) Preoperative membranous urethral length measurement and continence recovery following radical prostatectomy: a systematic review and meta-analysis. Eur Urol 71:368–378. 10.1016/j.eururo.2016.06.02327394644 10.1016/j.eururo.2016.06.023
44. Tutolo M Fossati N Van Der Aa F Magnetic resonance imaging for membranous urethral length assessment prior to radical prostatectomy: Can it really improve prostate cancer management? Eur Urol 2017 71 379 380 10.1016/j.eururo.2016.11.011 27887943
Tutolo M, Fossati N, Van Der Aa F et al (2017) Magnetic resonance imaging for membranous urethral length assessment prior to radical prostatectomy: Can it really improve prostate cancer management? Eur Urol 71:379–380. 10.1016/j.eururo.2016.11.01127887943 10.1016/j.eururo.2016.11.011
45. Lamberg H Shankar PR Singh K Preoperative prostate MRI predictors of urinary continence following radical prostatectomy Radiology 2022 303 99 109 10.1148/radiol.210500 35040671
Lamberg H, Shankar PR, Singh K et al (2022) Preoperative prostate MRI predictors of urinary continence following radical prostatectomy. Radiology 303:99–109. 10.1148/radiol.21050035040671 10.1148/radiol.210500
46. Boellaard TN Van Dijk-de Haan MC Heijmink SWTPJ Membranous urethral length measurement on preoperative MRI to predict incontinence after radical prostatectomy: a literature review towards a proposal for measurement standardization Eur Radiol 2023 10.1007/s00330-023-10180-7 37737870
Boellaard TN, Van Dijk-de Haan MC, Heijmink SWTPJ et al (2023) Membranous urethral length measurement on preoperative MRI to predict incontinence after radical prostatectomy: a literature review towards a proposal for measurement standardization. Eur Radiol. 10.1007/s00330-023-10180-737737870 10.1007/s00330-023-10180-7
47. Koraitim MM The Male Urethral Sphincter Complex Revisited: An Anatomical Concept and its Physiological Correlate J Urol 2008 179 1683 1689 10.1016/j.juro.2008.01.010 18343449
Koraitim MM (2008) The Male Urethral Sphincter Complex Revisited: An Anatomical Concept and its Physiological Correlate. J Urol 179:1683–1689. 10.1016/j.juro.2008.01.01018343449 10.1016/j.juro.2008.01.010
48. Wang X Liu S Xiong L Normal anatomy of urethral sphincter complex in young Chinese males on MRI Int Urol Nephrol 2014 46 1469 1476 10.1007/s11255-014-0686-1 24677000
Wang X, Liu S, Xiong L et al (2014) Normal anatomy of urethral sphincter complex in young Chinese males on MRI. Int Urol Nephrol 46:1469–1476. 10.1007/s11255-014-0686-124677000 10.1007/s11255-014-0686-1
49. Wagaskar VG Zaytoun O Kale P Technical tips in managing large median lobes during robot-assisted radical prostatectomy Eur Urol Open Sci 2022 45 32 37 10.1016/j.euros.2022.08.017 36186608
Wagaskar VG, Zaytoun O, Kale P et al (2022) Technical tips in managing large median lobes during robot-assisted radical prostatectomy. Eur Urol Open Sci 45:32–37. 10.1016/j.euros.2022.08.01736186608 10.1016/j.euros.2022.08.017
50. Schiavina R Bianchi L Borghesi M MRI displays the prostatic cancer anatomy and improves the bundles management before robot-assisted radical prostatectomy J Endourol 2018 32 315 321 10.1089/end.2017.0701 29256639
Schiavina R, Bianchi L, Borghesi M et al (2018) MRI displays the prostatic cancer anatomy and improves the bundles management before robot-assisted radical prostatectomy. J Endourol 32:315–321. 10.1089/end.2017.070129256639 10.1089/end.2017.0701
51. Mulhall JP Kattan MW Bennett NE Development of nomograms to predict the recovery of erectile function following radical prostatectomy J Sex Med 2019 16 1796 1802 10.1016/j.jsxm.2019.08.003 31521569
Mulhall JP, Kattan MW, Bennett NE et al (2019) Development of nomograms to predict the recovery of erectile function following radical prostatectomy. J Sex Med 16:1796–1802. 10.1016/j.jsxm.2019.08.00331521569 10.1016/j.jsxm.2019.08.003
52. Ward RD Purysko AS Magnetic resonance imaging of prostate adenocarcinoma: detection and staging Top Magn Reson Imaging 2020 29 17 30 10.1097/RMR.0000000000000226 32015292
Ward RD, Purysko AS (2020) Magnetic resonance imaging of prostate adenocarcinoma: detection and staging. Top Magn Reson Imaging 29:17–30. 10.1097/RMR.000000000000022632015292 10.1097/RMR.0000000000000226
53. Del Monte M Cipollari S Del Giudice F MRI-directed biopsy for primary detection of prostate cancer in a population of 223 men: MRI in-bore vs MRI-transrectal ultrasound fusion-targeted techniques BJR 2022 95 20210528 10.1259/bjr.20210528 34609900
Del Monte M, Cipollari S, Del Giudice F et al (2022) MRI-directed biopsy for primary detection of prostate cancer in a population of 223 men: MRI in-bore vs MRI-transrectal ultrasound fusion-targeted techniques. BJR 95:20210528. 10.1259/bjr.2021052834609900 10.1259/bjr.20210528
54. De Rooij M Hamoen EHJ Witjes JA Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis Eur Urol 2016 70 233 245 10.1016/j.eururo.2015.07.029 26215604
De Rooij M, Hamoen EHJ, Witjes JA et al (2016) Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol 70:233–245. 10.1016/j.eururo.2015.07.02926215604 10.1016/j.eururo.2015.07.029
55. Caglic I Kovac V Barrett T Multiparametric MRI—local staging of prostate cancer and beyond Radiol Oncol 2019 53 159 170 10.2478/raon-2019-0021 31103999
Caglic I, Kovac V, Barrett T (2019) Multiparametric MRI—local staging of prostate cancer and beyond. Radiol Oncol 53:159–170. 10.2478/raon-2019-002131103999 10.2478/raon-2019-0021
56. Eberhardt SC Local staging of prostate cancer with MRI: a need for standardization Radiology 2019 290 720 721 10.1148/radiol.2019182943 30667328
Eberhardt SC (2019) Local staging of prostate cancer with MRI: a need for standardization. Radiology 290:720–721. 10.1148/radiol.201918294330667328 10.1148/radiol.2019182943
57. Li W Sun Y Wu Y The quantitative assessment of using multiparametric MRI for prediction of extraprostatic extension in patients undergoing radical prostatectomy: a systematic review and meta-analysis Front Oncol 2021 11 771864 10.3389/fonc.2021.771864 34881183
Li W, Sun Y, Wu Y et al (2021) The quantitative assessment of using multiparametric MRI for prediction of extraprostatic extension in patients undergoing radical prostatectomy: a systematic review and meta-analysis. Front Oncol 11:771864. 10.3389/fonc.2021.77186434881183 10.3389/fonc.2021.771864
58. Krishna S Lim CS McInnes MDF Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer: MRI for Diagnosis of Extraprostatic Extension J Magn Reson Imaging 2018 47 176 185 10.1002/jmri.25729 28387981
Krishna S, Lim CS, McInnes MDF et al (2018) Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer: MRI for Diagnosis of Extraprostatic Extension. J Magn Reson Imaging 47:176–185. 10.1002/jmri.2572928387981 10.1002/jmri.25729
59. Martini A Soeterik TFW Haverdings H An algorithm to personalize nerve sparing in men with unilateral high-risk prostate cancer J Urol 2022 207 350 357 10.1097/JU.0000000000002205 34547922
Martini A, Soeterik TFW, Haverdings H et al (2022) An algorithm to personalize nerve sparing in men with unilateral high-risk prostate cancer. J Urol 207:350–357. 10.1097/JU.000000000000220534547922 10.1097/JU.0000000000002205
60. Lee SE Byun S-S Lee HJ Impact of variations in prostatic apex shape on early recovery of urinary continence after radical retropubic prostatectomy Urology 2006 68 137 141 10.1016/j.urology.2006.01.021 16777192
Lee SE, Byun S-S, Lee HJ et al (2006) Impact of variations in prostatic apex shape on early recovery of urinary continence after radical retropubic prostatectomy. Urology 68:137–141. 10.1016/j.urology.2006.01.02116777192 10.1016/j.urology.2006.01.021
61. Wenzel M Preisser F Mueller M Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy Int Urol Nephrol 2021 53 1297 1303 10.1007/s11255-021-02809-7 33606155
Wenzel M, Preisser F, Mueller M et al (2021) Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy. Int Urol Nephrol 53:1297–1303. 10.1007/s11255-021-02809-733606155 10.1007/s11255-021-02809-7
62. Sadimin ET Ye H Epstein JI Should the involvement of skeletal muscle by prostatic adenocarcinoma be reported on biopsies? Hum Pathol 2016 49 10 14 10.1016/j.humpath.2015.10.010 26826403
Sadimin ET, Ye H, Epstein JI (2016) Should the involvement of skeletal muscle by prostatic adenocarcinoma be reported on biopsies? Hum Pathol 49:10–14. 10.1016/j.humpath.2015.10.01026826403 10.1016/j.humpath.2015.10.010
63. Briganti A Larcher A Abdollah F Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores Eur Urol 2012 61 480 487 10.1016/j.eururo.2011.10.044 22078338
Briganti A, Larcher A, Abdollah F et al (2012) Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 61:480–487. 10.1016/j.eururo.2011.10.04422078338 10.1016/j.eururo.2011.10.044
64. Gandaglia G Fossati N Zaffuto E Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer Eur Urol 2017 72 632 640 10.1016/j.eururo.2017.03.049 28412062
Gandaglia G, Fossati N, Zaffuto E et al (2017) Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer. Eur Urol 72:632–640. 10.1016/j.eururo.2017.03.04928412062 10.1016/j.eururo.2017.03.049
65. Milonas D Venclovas Z Muilwijk T External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer Cent Eur J Urol 2020 73 19 25 10.5173/ceju.2020.0079
Milonas D, Venclovas Z, Muilwijk T et al (2020) External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer. Cent Eur J Urol 73:19–25. 10.5173/ceju.2020.007910.5173/ceju.2020.0079
66. Elsholtz FHJ Asbach P Haas M Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer Eur Radiol 2021 31 6116 6124 10.1007/s00330-020-07572-4 33585994
Elsholtz FHJ, Asbach P, Haas M et al (2021) Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur Radiol 31:6116–6124. 10.1007/s00330-020-07572-433585994 10.1007/s00330-020-07572-4
67. Mazzone E Dell’Oglio P Rosiello G Technical refinements in superextended robot-assisted radical prostatectomy for locally advanced prostate cancer patients at multiparametric magnetic resonance imaging Eur Urol 2021 80 104 112 10.1016/j.eururo.2020.09.009 32943260
Mazzone E, Dell’Oglio P, Rosiello G et al (2021) Technical refinements in superextended robot-assisted radical prostatectomy for locally advanced prostate cancer patients at multiparametric magnetic resonance imaging. Eur Urol 80:104–112. 10.1016/j.eururo.2020.09.00932943260 10.1016/j.eururo.2020.09.009
68. Panebianco V Salciccia S Cattarino S Use of Multiparametric MR with Neurovascular Bundle Evaluation to Optimize the Oncological and Functional Management of Patients Considered for Nerve-Sparing Radical Prostatectomy J Sex Med 2012 9 2157 2166 10.1111/j.1743-6109.2012.02794.x 22642466
Panebianco V, Salciccia S, Cattarino S et al (2012) Use of Multiparametric MR with Neurovascular Bundle Evaluation to Optimize the Oncological and Functional Management of Patients Considered for Nerve-Sparing Radical Prostatectomy. J Sex Med 9:2157–2166. 10.1111/j.1743-6109.2012.02794.x22642466 10.1111/j.1743-6109.2012.02794.x
69. Shieh AC Guler E Ojili V Extraprostatic extension in prostate cancer: primer for radiologists Abdom Radiol 2020 45 4040 4051 10.1007/s00261-020-02555-x
Shieh AC, Guler E, Ojili V et al (2020) Extraprostatic extension in prostate cancer: primer for radiologists. Abdom Radiol 45:4040–4051. 10.1007/s00261-020-02555-x10.1007/s00261-020-02555-x
70. Guerra A Alves FC Maes K Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features Cancer Imaging 2022 22 74 10.1186/s40644-022-00509-8 36550525
Guerra A, Alves FC, Maes K et al (2022) Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features. Cancer Imaging 22:74. 10.1186/s40644-022-00509-836550525 10.1186/s40644-022-00509-8
71. Pesapane F Standaert C De Visschere P Villeirs G T-staging of prostate cancer: identification of useful signs to standardize detection of posterolateral extraprostatic extension on prostate MRI Clin Imaging 2020 59 1 7 10.1016/j.clinimag.2019.08.007 31715511
Pesapane F, Standaert C, De Visschere P, Villeirs G (2020) T-staging of prostate cancer: identification of useful signs to standardize detection of posterolateral extraprostatic extension on prostate MRI. Clin Imaging 59:1–7. 10.1016/j.clinimag.2019.08.00731715511 10.1016/j.clinimag.2019.08.007
72. Soeterik TFW Van Melick HHE Dijksman LM Development and external validation of a novel nomogram to predict side-specific extraprostatic extension in patients with prostate cancer undergoing radical prostatectomy Eur Urol Oncol 2022 5 328 337 10.1016/j.euo.2020.08.008 32972895
Soeterik TFW, Van Melick HHE, Dijksman LM et al (2022) Development and external validation of a novel nomogram to predict side-specific extraprostatic extension in patients with prostate cancer undergoing radical prostatectomy. Eur Urol Oncol 5:328–337. 10.1016/j.euo.2020.08.00832972895 10.1016/j.euo.2020.08.008
73. Martini A Gupta A Lewis SC Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer BJU Int 2018 122 1025 1033 10.1111/bju.14353 29676063
Martini A, Gupta A, Lewis SC et al (2018) Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer. BJU Int 122:1025–1033. 10.1111/bju.1435329676063 10.1111/bju.14353
74. Soeterik TFW Van Melick HHE Dijksman LM External validation of the Martini nomogram for prediction of side-specific extraprostatic extension of prostate cancer in patients undergoing robot-assisted radical prostatectomy Urol Oncol: Semin Original Investig 2020 38 372 378 10.1016/j.urolonc.2019.12.028
Soeterik TFW, Van Melick HHE, Dijksman LM et al (2020) External validation of the Martini nomogram for prediction of side-specific extraprostatic extension of prostate cancer in patients undergoing robot-assisted radical prostatectomy. Urol Oncol: Semin Original Investig 38:372–378. 10.1016/j.urolonc.2019.12.02810.1016/j.urolonc.2019.12.028
75. Russo F Manfredi M Panebianco V Radiological Wheeler staging system: a retrospective cohort analysis to improve the local staging of prostate cancer with multiparametric MRI Minerva Urol Nefrol 2019 71 1 10.23736/S0393-2249.19.03248-X 30547907
Russo F, Manfredi M, Panebianco V et al (2019) Radiological Wheeler staging system: a retrospective cohort analysis to improve the local staging of prostate cancer with multiparametric MRI. Minerva Urol Nefrol 71:1. 10.23736/S0393-2249.19.03248-X30547907 10.23736/S0393-2249.19.03248-X
76. Sosnowski R Zagrodzka M Borkowski T The limitations of multiparametric magnetic resonance imaging also must be borne in mind Cent European J Urol 2016 69 22 23 10.5173/ceju.2016.e113 27123318
Sosnowski R, Zagrodzka M, Borkowski T (2016) The limitations of multiparametric magnetic resonance imaging also must be borne in mind. Cent European J Urol 69:22–23. 10.5173/ceju.2016.e11327123318 10.5173/ceju.2016.e113
